Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1995-03-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.92.7.2939PMID 7708752PMCID PMC42334
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• VIP: Molecular biology and neurobiological function

  2007cited by this paper
• Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway.

  1994cited by this paper
• Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells.

  1994cited by this paper
• The rat, mouse and human genes encoding the receptor for parathyroid hormone and parathyroid hormone-related peptide are highly homologous.

  1994cited by this paper
• Molecular cloning of the gene encoding the mouse parathyroid hormone/parathyroid hormone-related peptide receptor.

  1994cited by this paper
• Human vasoactive intestinal peptide1 receptors expressed by stable transfectants couple to two distinct signaling pathways.

  1994cited by this paper
• Differential signal transduction by five splice variants of the PACAP receptor

  1993cited by this paper
• Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide.

  1993cited by this paper
• Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor.

  1993cited by this paper
• Molecular basis of the little mouse phenotype and Implications for cell type-specific growth

  1993cited by this paper
• The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide

  1993cited by this paper
• Compilation of vertebrate-encoded transcription factors

  1992cited by this paper
• Definition of a tumor suppressor locus within human chromosome 3p21-p22.

  1992cited by this paper
• Interferon gamma response region in the promoter of the human DPA gene.

  1990cited by this paper
• High-resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones.

  1990cited by this paper
• Induction of the transcription factor IRF-1 and interferon-beta mRNAs by cytokines and activators of second-messenger pathways.

  1989cited by this paper
• A constitutive promoter directs expression of the nerve growth factor receptor gene.

  1988cited by this paper
• Vasoactive intestinal peptide and related peptides

  1988cited by this paper
• Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

  1988cited by this paper
• Splicing of messenger RNA precursors.

  1987cited by this paper
• Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer

  1987cited by this paper

• VIP and PACAP receptors in GtoPdb v.2023.1

  2023cites this paper
• PACAP and VIP Neuropeptides’ and Receptors’ Effects on Appetite, Satiety and Metabolism

  2023cites this paper
• VIP/PACAP signaling as an alternative target during hyperoxic exposure in preterm newborns.

  2021cites this paper
• VIP Receptors

  2021cites this paper
• Cryo-EM structure of an activated VIP1 receptor-G protein complex revealed by a NanoBiT tethering strategy

  2020cites this paper
• VIP and PACAP receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Neuroendocrine cells derived chemokine vasoactive intestinal polypeptide (VIP) in allergic diseases.

  2017cites this paper
• GI Peptides, Energy Balance, and Cancer

  2017cites this paper
• Diagnostics and treatment of cardiac achalasia and cardiospasm: guidelines of the Russian gastroenterological association

  2016cites this paper
• Sigmoid Oesophagus: Case Report and Review of Literature

  2016cites this paper
• The SNP rs9677 of VPAC1 gene is associated with glycolipid control and heart function in female patients with type 2 diabetes: A follow-up study.

  2016cites this paper
• Occurrence and Functions of PACAP in the Placenta

  2016cites this paper
• Vasoactive intestinal peptide suppresses macrophage‐mediated inflammation by downregulating interleukin‐17A expression via PKA‐ and PKC‐dependent pathways

  2015cites this paper
• Investigation of the Possible Functions of PACAP in Human Trophoblast Cells

  2014cites this paper
• Molecular Cloning and Characterization of Two Pig Vasoactive Intestinal Polypeptide Receptors (VPAC 1 -R and VPAC 2 -R)

  2014influential citation
• Molecular cloning and characterization of two pig vasoactive intestinal polypeptide receptors (VPAC1-R and VPAC2-R).

  2014cites this paper
• Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer.

  2014cites this paper
• Maturation in Inducing Human Dendritic Cell α TNF-Intestinal Peptide Synergizes with

  2013cites this paper
• Effects of pituitary adenylate cyclase activating polypeptide in the urinary system, with special emphasis on its protective effects in the kidney.

  2012cites this paper
• Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase‐activating polypeptide: IUPHAR Review 1

  2012cites this paper
• Pathogenesis of achalasia cardia.

  2012cites this paper
• Intestinal Epithelial Cell Apoptosis, Immunoregulatory Molecules, and Necrotizing Enterocolitis

  2012cites this paper
• Effet du VIP sur la modulation des réponses des cellules dendritiques

  2012cites this paper
• Characterization and use of a rabbit-anti-mouse VPAC1 antibody by flow cytometry.

  2012cites this paper
• ituitary adenylate cyclase-activating polypeptide plays an anti-inflammatory ole in endotoxin-induced airway inflammation : In vivo study with gene-deleted ice

  2011cites this paper
• Metadata of the chapter that will be visualized online

  2011cites this paper
• Alterations of Vasoactive Intestinal Polypeptide Receptors in Allergic Rhinitis

  2011cites this paper
• megakaryocytes and platelets Characterization of vasoactive intestinal peptide receptors on human

  2011cites this paper
• Vasoactive Intestinal Peptide (VIP) and VIP Receptors-Elucidation of Structure and Function for Therapeutic Applications

  2011cites this paper
• Quantifizierung von VPAC2-Rezeptor-Protein in Mastzellen normaler Haut

  2011cites this paper
• Extragastrointestinal functions and transcriptional regulation of secretin and secretin receptors

  2011cites this paper
• Vasoactive intestinal peptide signaling axis in human leukemia.

  2011cites this paper
• Vasoactive intestinal peptide receptor 1 is downregulated during expansion of antigen-specific CD8 T cells following primary and secondary Listeria monocytogenes infections.

  2011cites this paper
• Pituitary adenylate cyclase-activating polypeptide plays an anti-inflammatory role in endotoxin-induced airway inflammation: In vivo study with gene-deleted mice

  2011cites this paper
• Pituitary adenylate cyclase activating polypeptide: an important vascular regulator in human skin in vivo.

  2010cites this paper
• Achalasia: will genetic studies provide insights?

  2010cites this paper
• The Expression of Vasoactive Intestinal Peptide Receptor 1 Is Negatively Modulated by MicroRNA 525-5p

  2010cites this paper
• Expression Analysis of PAC1-R and PACAP Genes in Zebrafish Embryos

  2010cites this paper
• Oligonucleotide DNA Microarray Profiling of Lung Adenocarcinoma Revealed Significant Downregulation and Deletions of Vasoactive Intestinal Peptide Receptor 1

  2010cites this paper
• VIP modulates the pro‐inflammatory maternal response, inducing tolerance to trophoblast cells

  2009cites this paper
• Pituitary adenylate cyclase-activating polypeptide

  2009cites this paper
• Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery

  2009cites this paper
• Age‐dependent association of idiopathic achalasia with vasoactive intestinal peptide receptor 1 gene

  2009cites this paper
• The genomic organization of the human GLP-1 receptor gene

  2009cites this paper
• A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B *2705 in Sardinia

  2008cites this paper
• cAMP PRODUCED BY PITUITARY ADENYLATE CYCLASE‐ACTIVATING POLYPEPTIDE 27 INHIBITS ATRIAL NATRIURETIC PEPTIDE SECRETION IN RABBIT BEATING ATRIA

  2008cites this paper
• Targeting growth factors in lung cancer.

  2008cites this paper
• Effects of PACAP on Survival and Renal Morphology in Rats Subjected to Renal Ischemia/Reperfusion

  2008cites this paper
• Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.

  2008cites this paper
• Pituitary adenylate cyclase-activating polypeptide stimulates renin secretion via activation of PAC1 receptors.

  2007influential citation
• Expression and fine mapping of murine vasoactive intestinal peptide receptor 1

  2007cites this paper
• Vasoactive intestinal polypeptide enhances oral tolerance by regulating both cellular and humoral immune responses

  2007cites this paper
• Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator.

  2007cites this paper
• PACAP, VIP and their receptors in the metazoa: insights about the origin and evolution of the ligand-receptor pair.

  2007cites this paper
• Pituitary Adenylate Cyclase – Activating Polypeptide Stimulates Renin Secretion via Activation of PAC 1 Receptors

  2007influential citation
• Stimulation of intestinal secretion by vasoactive intestinal peptide and cholera toxin.

  2007cites this paper
• Unconventional binding sites and receptors for VIP and related peptides PACAP and PHI/PHM: an update.

  2007cites this paper
• Novel concepts of neuropeptide-based drug therapy: vasoactive intestinal polypeptide and its receptors.

  2006cites this paper
• Sp1/Sp3 binding is associated with cell-specific expression of the glucose-dependent insulinotropic polypeptide receptor gene.

  2006cites this paper
• Hypoxia regulation of expression and angiogenic effects of vasoactive intestinal peptide (VIP) and VIP receptors in LNCaP prostate cancer cells.

  2006cites this paper
• Ontogeny of PACAP receptors in the human cerebellum: perspectives of therapeutic applications.

  2006cites this paper
• Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis.

  2006cites this paper
• Localization and characterization of pituitary adenylate cyclase‐activating polypeptide receptors in the human cerebellum during development

  2006cites this paper
• Identification and characterization of five-transmembrane isoforms of human vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors.

  2006cites this paper
• Endogenous ligands of PACAP/VIP receptors in the autocrine-paracrine regulation of the adrenal gland.

  2006cites this paper
• Does dysregulation of key epigenetic and biochemical pathways occur in postulated vasoactive neuropeptide autoimmune disorders?

  2005cites this paper
• Antisecretory actions of a novel vasoactive intestinal polypeptide (VIP) antagonist in human and rat small intestine

  2005cites this paper
• Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.

  2005cites this paper
• The Sp transcription factors are involved in the cellular expression of the human glucose-dependent insulinotropic polypeptide receptor gene and overexpressed in adrenals of patients with Cushing's syndrome.

  2005cites this paper
• Placental expression of substance P and vasoactive intestinal peptide: evidence for a local effect on hormone release.

  2005cites this paper
• Pharmacology and Therapeutics of Asthma and COPD

  2004cites this paper
• Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis

  2004cites this paper
• Vasoactive Intestinal Peptide (VIP)

  2004cites this paper
• A Natural Variant Type II G Protein-coupled Receptor for Vasoactive Intestinal Peptide with Altered Function*

  2004cites this paper
• Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells

  2004cites this paper
• Classification between normal and tumor tissues based on the pair-wise gene expression ratio

  2004cites this paper
• The Significance of Vasoactive Intestinal Peptide in Immunomodulation

  2004cites this paper
• Title Classification between normal and tumor tissues based on thepair-wise gene expression ratio

  2004cites this paper
• New Bronchodilator Drugs

  2004cites this paper
• Duplicated receptors for VIP and PACAP (VPAC1R and PAC1R) in a teleost fish, Fugu rubripes.

  2004cites this paper
• VIP receptor 1 (VPAC1) promoter targets the expression of a reporter gene to cerebellum and adrenal medulla in transgenic mice.

  2003cites this paper
• Neuropeptides of the pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide/growth hormone-releasing hormone/secretin family in testis

  2003cites this paper
• Gastrin peptides: pathophysiologic role in gastrointestinal carcinogenesis

  2003cites this paper
• PACAP: Discovery, Gene, Receptors

  2003cites this paper
• Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis.

  2003cites this paper
• PACAP Receptor Signaling

  2003cites this paper
• Roles of Vasoactive Intestinal Peptide (VIP) in the Expression of Different Immune Phenotypes by Wild-Type Mice and T Cell-Targeted Type II VIP Receptor Transgenic Mice1

  2003cites this paper
• The Biological Significance of PACAP and PACAP Receptors in Human Tumors: From Cell Lines to Cancers

  2003cites this paper
• Pituitary Adenylate Cyclase-Activating Polypeptide

  2003cites this paper
• Pituitary Adenylate Cyclase-activating Polypeptide (PACAP(1–38)) Enhances N-Methyl-d-aspartate Receptor Function and Brain-derived Neurotrophic Factor Expression via RACK1*

  2003cites this paper
• VPAC receptors for VIP and PACAP.

  2002cites this paper
• Vasoactive intestinal peptide (VIP) inhibits the proliferation of bone marrow progenitors through the VPAC1 receptor.

  2002cites this paper
• A vasoactive intestinal peptide receptor analog alters the expression of homeobox genes.

  2002cites this paper
• Vasoactive intestinal peptide (VIP) enhances the cell motility of androgen receptor-transfected DU-145 prostate cancer cells (DU-145/AR).

  2002cites this paper
• Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate.

  2002cites this paper
• PACAP and its receptors exert pleiotropic effects in the nervous system by activating multiple signaling pathways.

  2002cites this paper
• Vasoactive Intestinal Peptide Receptor-1 (VPAC-1) Is a Novel Gene Target of the Hemolymphopoietic Transcription Factor Ikaros*

  2002cites this paper
• Transgenic Mice Cell-Targeted Type II VIP Receptor Phenotypes by Wild-Type Mice and T in the Expression of Different Immune Roles of Vasoactive Intestinal Peptide (VIP)

  2002cites this paper
• Carbocyanin-markierte Derivate des vasoaktiven intestinalen Peptids fü die Tumordiagnostik

  2002cites this paper
• A lipophilic vasoactive intestinal peptide analog enhances the antiproliferative effect of chemotherapeutic agents on cancer cell lines

  2001cites this paper